Dr. Neka Miller, PhD

• PhD in Molecular Pharmacology
• Over 15 years of experience
• Expertise in neuroscience, pharmacology, medical writing, and more

---

Reviewer Experience

Neka Miller holds a PhD in Molecular Pharmacology and Experimental Therapeutics from SUNY Buffalo/Roswell Park Cancer Institute, and has spent over 15 years researching, writing, and publishing in pharmacology, oncology, neuroscience, and traumatic brain injury. Her postdoctoral work took her from the University of Nebraska Medical Center's Eppley Cancer Institute to therapeutics development in neuroscience, building a research background that spans cancer biology and brain injury. As a technical writer, Miller has authored manuals, custom reports with data visualizations, protocols, method sections, and manuscripts, in addition to publishing in peer-reviewed scientific journals. She currently serves as Director of Institutional Effectiveness and an Adjunct Professor in the Doctor of Healthcare & Education Leadership (Ed.D.) program at Clarkson College.

Education

• SUNY University at Roswell Park
• SUNY University at Buffalo

Credentials and Certifications

• Ph.D., Molecular Pharmacology and Experimental Therapeutics
• Bachelor of Science, Biochemical Pharmacology
• Bachelor of Arts, Psychology

Published Works

-Simms, N.A., Rajput, A., Sharratt, E.A. et al. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. BMC Cancer 12, 221 (2012). https://doi.org/10.1186/1471-2407-12-221

-Sabbah DA, Simms NA, Brattain MG, Vennerstrom JL, Zhong H. Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorg Med Chem Lett. 2012 Jan 15;22(2):876-80. doi: 10.1016/j.bmcl.2011.12.044. Epub 2011 Dec 13. PMID: 22212721; PMCID: PMC4472446. https://www.researchgate.net/publication/51975767_Biological_evaluation_and_docking_studies_of_recently_identified_inhibitors_of_phosphoinositide-3-kinases

-Ongchin M, Sharratt E, Dominguez I, Simms NA, Wang J, Cheney R, LeVea C, Brattain M, Rajput A. The effects of epidermal growth factor receptor activation and attenuation of the TGFbeta pathway in an orthotopic model of colon cancer. J Surg Res. 2009 Oct;156(2):250-6. doi: 10.1016/j.jss.2009.02.002. Epub 2009 Mar 5. PMID: 19524264.https://www.sciencedirect.com/science/article/abs/pii/S0022480409000493

-Are C, Simms NA, Rajput A, Brattain M. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer. HPB (Oxford). 2010 Sep;12(7):498-506. doi: 10.1111/j.1477-2574.2010.00219.x. Erratum in: HPB (Oxford). 2011 Aug;13(8):593. Rajupt, Ashwani (corrected to Rajput, Ashwani). PMID: 20815859; PMCID: PMC3030759.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030759/

Recommended Reads

What Happens During Menopause?

What is HbA1c?

Symptoms of Adrenal Insufficiency

How to Increase Your Chances of Getting Pregnant